Bladder cancer
Also known as: urinary bladder cancer, urothelial carcinoma of the bladder, transitional cell carcinoma of the bladder, non-muscle-invasive bladder cancer, muscle-invasive bladder cancer
Bladder cancer is a malignant tumour arising from tissues of the urinary bladder, most commonly the urothelial lining. Blood in the urine is the most common presenting symptom, and diagnosis generally requires cystoscopy, imaging and pathological examination of tissue removed during transurethral resection. Treatment depends on tumour grade, stage and whether the cancer has invaded the bladder muscle, and may include surgery, intravesical therapy, systemic medicines, radiotherapy or combined treatment. [1, 2, 3, 4]
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Attend all scheduled urology and oncology appointments, including cystoscopic surveillance after treatment.
- •Report any new or recurrent blood in the urine, clot passage, fever or urinary obstruction promptly.
- •Stop smoking and avoid occupational exposure to known bladder carcinogens where possible.
- •Maintain adequate hydration unless a clinician has advised fluid restriction.
- •Coordinate any herbal, supplement or complementary treatment with the treating cancer team and pharmacist.
Cautions & Contraindications
- •Do not use acupuncture or Chinese herbal medicine as a substitute for surgery, intravesical therapy, chemotherapy, immunotherapy or radiotherapy. [3, 4][,]
- •Do not needle over unhealed surgical sites, tumour-related bleeding, active infection or a distended obstructed bladder. [4, 6][,]
- •Avoid strong Blood-moving herbs during active haematuria, thrombocytopenia or anticoagulation. [3, 4][,]
- •Do not use Aristolochia species or aristolochic-acid-containing products because of urothelial carcinogenicity and severe nephrotoxicity. [3, 4][,]
- •During pregnancy, avoid LI4, SP6, GB21 and strong lower-abdominal or lumbosacral stimulation unless clinically justified and delivered by a competent practitioner. [6][]
When to reassess or seek care again
- •Reassess symptom burden, urinary function, treatment adverse effects and red flags at every visit.
- •Confirm that haematuria, dysuria, urinary obstruction and recurrent infection remain under active urological assessment.
- •Reassess supportive-care goals after surgery, intravesical treatment, chemotherapy, immunotherapy or radiotherapy changes.
- •Refer immediately if clot retention, inability to urinate, fever, uncontrolled bleeding, acute kidney symptoms or clinical deterioration emerges.
- •Do not continue routine acupuncture over unhealed surgical areas, active infection, severe thrombocytopenia or unexplained treatment-related deterioration.
- •Review the need for treatment after two to four sessions and discontinue when no meaningful supportive benefit is identified.
Frequently Asked Questions
What is the most common symptom of bladder cancer?+
Blood in the urine is the most common symptom and may be painless, intermittent or visible only once; it still requires medical investigation. [1, 2]
How is bladder cancer diagnosed?+
Diagnosis commonly involves urine assessment, imaging, cystoscopy and pathological examination of tissue removed during transurethral resection or biopsy. [2, 4]
How is bladder cancer treated?+
Treatment depends on grade, stage and muscle invasion and may include transurethral surgery, intravesical medicines, radical cystectomy, chemotherapy, immunotherapy or radiotherapy. [3, 4]
Can acupuncture treat bladder cancer?+
Acupuncture may be considered for selected supportive-care symptoms, but it cannot remove the tumour, determine its stage or replace surgery, intravesical treatment, systemic therapy or radiotherapy. [3, 4, 6]
Are Chinese herbal medicines automatically safe during cancer treatment?+
No. Herbal products may affect bleeding, liver or kidney function and may interact with anticancer, anticoagulant or immunosuppressive medicines, so use requires oncology and pharmacy review. [3, 4]
Why are classical TCM patterns not equivalent to a cancer diagnosis?+
Classical descriptions of urinary difficulty, blood in the urine and fluid transformation provide a traditional pattern framework, but they predate cystoscopy, histopathology and modern tumour staging and cannot identify bladder cancer. [2, 4, 5]
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Cancer Council Australia · 2026
- National Cancer Institute · 2024
- National Cancer Institute · 2025
- European Association of Urology · 2026
- Chinese Text Project · 200
- World Health Organization · 2021
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.